Xu Jing
BioMinerva Group, 11553 Hadar Drive, San Diego, CA 92126, USA.
IDrugs. 2004 Sep;7(9):841-5.
The Strategic Research Institute's inaugural BioAsia Licensing and Deal-Making Summit, co-organized by the BioMinerva Group, attracted industrial leaders in biotechnology and pharmaceuticals from both sides of the Pacific Ocean. Topics discussed at the 2-day conference spanned from trans-Pacific licensing and partnering trends led by Japan-US deals, the changing landscape of the Japanese pharmaceutical industry, and trans-Pacific partnering strategies to perspectives of Asia-Pacific markets and successful investment strategies. The emerging Chinese biotechnology and pharmaceutical industry was also covered prominently, including assessments of the Chinese market, discussions on intellectual property, regulatory and tax issues, as well as case studies of Sino-US collaborations and technology showcases from Chinese biotech companies.
战略研究所首届生物亚洲授权与交易峰会由生物密涅瓦集团共同主办，吸引了来自太平洋两岸的生物技术和制药行业领袖。在为期两天的会议上讨论的主题包括以日美交易为主导的跨太平洋授权与合作趋势、日本制药行业不断变化的格局、跨太平洋合作战略，以及亚太市场的前景和成功的投资策略。新兴的中国生物技术和制药行业也得到了重点关注，包括对中国市场的评估、关于知识产权、监管和税收问题的讨论，以及中美合作案例研究和中国生物技术公司的技术展示。
